BioLife Solutions, Inc. Write off of Deferred Debt Issuance Cost
BioLife Solutions, Inc. (BLFS) reported Write off of Deferred Debt Issuance Cost of $68.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:WriteOffOfDeferredDebtIssuanceCost · last filed 2019-03-15
- BioLife Solutions, Inc. write off of deferred debt issuance cost for the quarter ending 2017-12-31 was $336.00.
- BioLife Solutions, Inc. write off of deferred debt issuance cost for the quarter ending 2017-09-30 was $67.66K.
- BioLife Solutions, Inc. write off of deferred debt issuance cost for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. write off of deferred debt issuance cost for the quarter ending 2016-12-31 was $0.00.
- BioLife Solutions, Inc. write off of deferred debt issuance cost for fiscal 2017 was $68.00K, a 21.60% decline from fiscal 2016.
- BioLife Solutions, Inc. write off of deferred debt issuance cost for fiscal 2016 was $86.74K.
| Period end | Write off of Deferred Debt Issuance Cost 3 month | Write off of Deferred Debt Issuance Cost 6 month | Write off of Deferred Debt Issuance Cost 9 month | Write off of Deferred Debt Issuance Cost 12 month | Write off of Deferred Debt Issuance Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2017-12-31 | $336.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $68.00K derived: sum of 2 quarters · filed 2019-03-15 | $68.00K derived: sum of 3 quarters · filed 2019-03-15 | $68.00K 10-K · filed 2019-03-15 | $108.66K 10-K · filed 2018-03-09 |
| 2017-09-30 | $67.66K 10-Q · filed 2018-11-08 | $67.66K derived: sum of 2 quarters · filed 2018-11-08 | $67.66K 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-11 | $0.00 10-Q · filed 2017-08-11 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $0.00 derived: sum of 2 quarters · filed 2018-03-09 | $86.74K derived: sum of 3 quarters · filed 2018-03-09 | $86.74K 10-K · filed 2018-03-09 | |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-09 | $86.74K derived: sum of 2 quarters · filed 2017-11-09 | $86.74K 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $86.74K 10-Q · filed 2017-08-11 | $86.74K 10-Q · filed 2017-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |